ArticleBioscience of microbiota, food and health2024

Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trial.

Hidenori Ohkubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.